
Join to View Full Profile
200 1st St SWRochester, MN 55905
Phone+1 507-284-2511
Dr. Haddad is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of MinnesotaFellowship, Hematology and Medical Oncology, 2004 - 2007
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2001 - 2004
- Creighton University School of MedicineClass of 2001
- Marquette UniversityB.S., Biology, Magna Cum Laude, 1991 - 1995
Certifications & Licensure
- MN State Medical License 2002 - 2025
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- HIMSS Future50 Clinical Leader Health Information and Management Systems Society, 2021
- Best Teacher- New Faculty, by the Mayo Clinic Internal Medicine Residency Program 2013
- Department of Medicine Educational Excellence Award 2008
- Join now to see all
Clinical Trials
- Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast Cancer Start of enrollment: 2008 Jul 30
- Alisertib and Fulvestrant in Treating Patients With Hormone Receptor Positive Breast Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery Start of enrollment: 2014 Dec 05
- Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer Start of enrollment: 2017 Jul 06
- Join now to see all
Publications & Presentations
PubMed
- Impact of adding palbociclib on treatment adherence to ongoing adjuvant endocrine treatment in the global randomized PALLAS randomized trial in patients with early bre...Eileen Shinn, David Zahrieh, Angela DeMichele, Nick Zdenkowski, Julie Lemieux
Breast Cancer Research and Treatment. 2025-06-01 - Real-World Evidence on Prescribing Patterns and Clinical Outcomes of Metastatic Breast Cancer Patients Treated with PARP Inhibitors: The Mayo Clinic Experience.Nusrat Jahan, Jodi Taraba, Nicholas J Boddicker, Karthik V Giridhar, Roberto A Leon-Ferre
Clinical Breast Cancer. 2025-04-01 - 2 citationsTransforming the oncology data paradigm by creating, capturing, and retrieving structured cancer data at the point of care: A Mayo Clinic pilot.Amye J Tevaarwerk, Dhauna Karam, Clare A Gatten, Elizabeth S Harlos, Matthew J Maurer
Cancer. 2025-01-01
Journal Articles
- Smoking and quality of life among survivors of breast, colorectal and endometrial cancers in a prospective cohort studyJang S, Prizment A, Haddad T, Robien K, Lazovich D, J Cancer Surviv, 1/1/2011
- Nonpharmacologic Complementary Therapies for Symptom Management in Breast Cancer SurvivorsBlaes A, Kreitzer MJ, Torkelson C, Haddad T, Semin Oncol, 1/1/2011
- Conflict of interest in economic analysis of aromatase inhibitors in breast cancer: a systematic reviewJang S, Chae YK, Haddad T, and Majhail N, Breast Cancer Res Treat, 1/1/2010
- Join now to see all
Press Mentions
- How Allina Doctors Are Deploying AI to Double-Check Cancer ScreeningsApril 10th, 2025
- Chapter 4: The Ghost in the MachineMarch 4th, 2025
- Breaking down Barriers in Patient-Centered Clinical ResearchFebruary 3rd, 2025
- Join now to see all
Professional Memberships
- Member
- American Association of Cancer ResearchMember
- Healthcare Information and Management Systems SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: